2018, Number 6
Mortalidad por cáncer mamario, prostático y cervicouterino, años perdidos y costos de los programas. México, 2013 a 2016
PDF size: 159.72 Kb.
ABSTRACTIntroduction: In Mexico, large expenditure is made on resources for cervical and breast cancer early detection, but the Ministry of Health and the Mexican Institute of Social Security do not have a program for the detection of prostate cancer. Objective: To compare breast, cervical and prostate cancer mortality, as well as years lost in Mexico from 2013 to 2016 versus the cost of programs. Method: Overall mortality figures were taken from the number of deaths for each type of cancer based on ICD-10. The number of years lost were obtained according to life expectancy in Mexico (72 years for men and 77 years for women). Results: Prostate cancer mortality is higher than that of breast cancer, but lost years in women due to breast cancer are higher. The cost of programs for breast and prostate cancer from 2013 to 2016 in both institutions was 3 036 322 156 Mexican Pesos. Conclusion: Institutional programs have not had an impact to the benefit of the population in spite of their cost and prostate cancer has not been correctly evaluated. It is necessary for strategies to be assessed and redesigned in order to optimize expenditure and benefit the population.
Organización Panamericana de la Salud/Organización Mundial de la Salud. [Sitio web]. Expertos regionales discuten enfoques para el tamizaje y detección temprana del cáncer de próstata en las Américas. Disponible en: http //www.paho.org/hq/index php?option=com_content&- view=article&id=13818&Itemid=42459&lang=es